Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Data from a late-stage study shows that treatment with flexible doses of ABBV's tavapadon reduced the burden of Parkinson's ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Philip Stevens, a 66 year old from Hampshire, has received £70,000 from his GP following a lawsuit after he was given the ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

Annovis Bio, Inc. operates in the biopharmaceutical industry, focusing on developing therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Their primary product, ...

According to NHS warnings, Ropinirole can cause patients to start binge eating, gambling and shopping uncontrollably, or have ...

Why digital measurements startup Koneksa Health thinks it can help pharma measure if their drugs are effective in people with ...